Marcel Kaiser

565 total citations
22 papers, 438 citations indexed

About

Marcel Kaiser is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Marcel Kaiser has authored 22 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Marcel Kaiser's work include Diabetes Treatment and Management (18 papers), Diabetes Management and Research (16 papers) and Metabolism, Diabetes, and Cancer (7 papers). Marcel Kaiser is often cited by papers focused on Diabetes Treatment and Management (18 papers), Diabetes Management and Research (16 papers) and Metabolism, Diabetes, and Cancer (7 papers). Marcel Kaiser collaborates with scholars based in Germany, United Kingdom and Canada. Marcel Kaiser's co-authors include Robert J. Ligthelm, Jiten Vora, Andreas Liebl, Kamlesh Khunti, Rudolf Prager, Richard M. Bergenstal, Katharina Binz, Baptist Gallwitz, Jean‐François Yale and Grzegorz Dzida and has published in prestigious journals such as Diabetes, Journal of the American Geriatrics Society and American Journal of Neuroradiology.

In The Last Decade

Marcel Kaiser

20 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcel Kaiser Germany 10 385 94 88 65 43 22 438
Joseph M. Tibaldi United States 14 393 1.0× 127 1.4× 101 1.1× 82 1.3× 50 1.2× 26 524
Rengna Yan China 12 173 0.4× 69 0.7× 98 1.1× 74 1.1× 53 1.2× 33 332
Niyaz R Gosmanov United States 7 250 0.6× 118 1.3× 104 1.2× 40 0.6× 95 2.2× 10 379
Udi Fainberg Denmark 5 256 0.7× 102 1.1× 69 0.8× 58 0.9× 50 1.2× 8 295
Isaac Sinay Argentina 7 261 0.7× 64 0.7× 61 0.7× 29 0.4× 23 0.5× 15 319
N Bağriaçik Türkiye 6 240 0.6× 123 1.3× 84 1.0× 63 1.0× 21 0.5× 12 316
М. А. Коваренко Russia 6 283 0.7× 134 1.4× 40 0.5× 102 1.6× 51 1.2× 15 337
Björn A. Menge Germany 8 228 0.6× 191 2.0× 95 1.1× 66 1.0× 53 1.2× 9 312
Katherine A. Hughes United Kingdom 9 279 0.7× 45 0.5× 46 0.5× 22 0.3× 56 1.3× 14 358
D. Ugolotti Italy 4 209 0.5× 115 1.2× 67 0.8× 18 0.3× 70 1.6× 5 302

Countries citing papers authored by Marcel Kaiser

Since Specialization
Citations

This map shows the geographic impact of Marcel Kaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel Kaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel Kaiser more than expected).

Fields of papers citing papers by Marcel Kaiser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcel Kaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel Kaiser. The network helps show where Marcel Kaiser may publish in the future.

Co-authorship network of co-authors of Marcel Kaiser

This figure shows the co-authorship network connecting the top 25 collaborators of Marcel Kaiser. A scholar is included among the top collaborators of Marcel Kaiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcel Kaiser. Marcel Kaiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacob, Louis, Marcel Kaiser, & Karel Kostev. (2021). Incidence of antiepileptic drug therapy and factors associated with their prescribing in outpatients with diabetic polyneuropathy. Primary care diabetes. 15(3). 535–540. 1 indexed citations
2.
Seidu, Samuel, Linda Mellbin, Marcel Kaiser, & Kamlesh Khunti. (2020). Will oral semaglutide be a game-changer in the management of type 2 diabetes in primary care?. Primary care diabetes. 15(1). 59–68. 10 indexed citations
3.
Buse, John B., Matthew J. Crowley, Jan W. Eriksson, et al.. (2020). 957-P: Efficacy of Oral Semaglutide According to Background Medication: An Exploratory Subgroup Analysis of the PIONEER Trial Program. Diabetes. 69(Supplement_1). 2 indexed citations
4.
Boom, Louisa van den, Marcel Kaiser, & Karel Kostev. (2020). Prevalence of insulin as a first‐line therapy and associated factors in people with type 2 diabetes in German primary care practices. Diabetic Medicine. 37(8). 1333–1339. 6 indexed citations
5.
Boom, Louisa van den, et al.. (2020). Multimorbidity Among Adult Outpatients With Type 1 Diabetes in Germany. Journal of Diabetes Science and Technology. 16(1). 152–160. 6 indexed citations
6.
Kostev, Karel, Stefan Gölz, B. Scholz, Marcel Kaiser, & Stefan Pscherer. (2019). Time to Insulin Initiation in Type 2 Diabetes Patients in 2010/2011 and 2016/2017 in Germany. Journal of Diabetes Science and Technology. 13(6). 1129–1134. 8 indexed citations
7.
Yale, Jean‐François, Taner Damcı, Marcel Kaiser, et al.. (2013). Initiation of once daily insulin detemir is not associated with weight gain in patients with type 2 diabetes mellitus: results from an observational study. Diabetology & Metabolic Syndrome. 5(1). 56–56. 7 indexed citations
8.
Caputo, Salvatore, Henning Andersen, Marcel Kaiser, et al.. (2013). Effect of Baseline Glycosylated Hemoglobin A1C on Glycemic Control and Diabetes Management following Initiation of Once-daily Insulin Detemir in Real-Life Clinical Practice. Endocrine Practice. 19(3). 462–470. 15 indexed citations
9.
10.
Lüdemann, J, et al.. (2013). Insulin degludec: Reduktion von Hypoglykämien unter einer Basis-Bolus Therapie bei Patienten mit Diabetes mellitus Typ 1 oder 2. Diabetologie und Stoffwechsel. 8(1). 35–42. 1 indexed citations
11.
Ligthelm, Robert J., Marcel Kaiser, Jiten Vora, & Jean‐François Yale. (2012). Insulin Use in Elderly Adults: Risk of Hypoglycemia and Strategies for Care. Journal of the American Geriatrics Society. 60(8). 1564–1570. 60 indexed citations
12.
Nosek, Leszek, Lutz Heinemann, C. W. Gottschalk, et al.. (2012). Insulin aspart has a shorter duration of action than human insulin over a wide dose‐range. Diabetes Obesity and Metabolism. 15(1). 77–83. 19 indexed citations
13.
Khunti, Kamlesh, Salvatore Caputo, Taner Damcı, et al.. (2012). The safety and efficacy of adding once‐daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries. Diabetes Obesity and Metabolism. 14(12). 1129–1136. 44 indexed citations
14.
Caputo, Salvatore, Henning Andersen, Marcel Kaiser, et al.. (2012). EFFECT OF BASELINE HBA1C ON GLYCEMIC CONTROL AND DIABETES MANAGEMENT FOLLOWING INITIATION OF ONCE-DAILY INSULIN DETEMIR IN REAL-LIFE CLINICAL PRACTICE. 4 indexed citations
15.
Ross, Stuart A., Grzegorz Dzida, Jiten Vora, et al.. (2011). Impact of weight gain on outcomes in type 2 diabetes. Current Medical Research and Opinion. 27(7). 1431–1438. 73 indexed citations
16.
Meneghini, Luigi, Sara Artola, Salvatore Caputo, et al.. (2010). Practical guidance to insulin management. Primary care diabetes. 4. S43–S56. 12 indexed citations
17.
Liebl, Andreas, Rudolf Prager, Katharina Binz, et al.. (2008). Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial. Diabetes Obesity and Metabolism. 11(1). 45–52. 125 indexed citations
18.
19.
Nosek, Leszek, Lutz Heinemann, Marcel Kaiser, Sabine Arnolds, & Tim Heise. (2003). No Increase in the Duration of Action with Rising Doses of Insulin Aspart. Diabetes. 52. 128–129. 12 indexed citations
20.
Kaiser, Marcel, et al.. (1987). Anterior cervical meningoceles in neurofibromatosis.. American Journal of Neuroradiology. 7(6). 1105–1105. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph M. Tibaldi Breakdown of academic impact, for papers by Rengna Yan Breakdown of academic impact, for papers by Niyaz R Gosmanov Breakdown of academic impact, for papers by Udi Fainberg Breakdown of academic impact, for papers by Isaac Sinay Breakdown of academic impact, for papers by N Bağriaçik Breakdown of academic impact, for papers by М. А. Коваренко Breakdown of academic impact, for papers by Björn A. Menge Breakdown of academic impact, for papers by Katherine A. Hughes Breakdown of academic impact, for papers by D. Ugolotti
Rankless by CCL
2026